Anti-HIV Activity in
Vitro of MGN-3, an Activated Arabinoxylane from Rice Bran
Biochemical AND BIOPHYSICAL
RESEARCH COMMUNICATIONS 243, 25-29 (1998)
ARTICLE No. RC978047
Anti-HIV Activity in
Vitro of MGN-3, an Activated Arabinoxylane from Rice Bran
Mamdooh Ghoneum
Department of Otolaryngology,
Drew University of Medicine and Science, 1621 E. 120th Street, Los Angeles,
California 90059
Received December 19,
1997
MATERIALS AND METHODS
MGN-3.
MGN-3
is an arabinoxylane extracted from rice bran that is treated enzymatically
with an extract from Basidiomycetes mycelia. It is a polysaccharide
that contains B-1, 4-xylopyronase hemicellulose (Fig.1). MGN-3 is
commercially known as Biobran (Daiwa Pharm., Co., Ltd., Tokyo, Japan)
Complete
medium
(CM).
RPMI-1640 (Sigma) was supplemented with 1% antibiotics (v/v) and 20% (v/v)
fetal bovine serum and recombinant IL2.
Production
of HIV-1 p24 antigen.MNCs from 3 healthy individuals were incubated
(37°C) with PHA (5µg/ml) for 3 days and then washed before incubation
(37°C, 1hr) with HIV-1 SF strain (HIV-1 p24 of 3000 pg/106
cells). MNCs were then washed 3x with PBS to remove unbound virus. Infected
cells were incubated (37°C, 7 days) either with or without MGN-3 at
various concentrations (0-100µ/ml), in CM. Half of the medium was
changed twice per week with corresponding MGN-3 concentrations. At the
end of the incubation period, culture supernatants of HIV-1 infected cells
were collected and analyzed for viral production. HIV-1 p24 was measured
by antigen capturing ELISA using a commercially available kit (DuPont NEN,
Boston, MA) according to the protocol provided by the manufacturer.
Syncytia
formation. A slight modification of Johnson and Walker (3) cell fusion
assay was used. Briefly, MNC from 5 AIDS patients were cultured with PHA
and in the presence or absence of MGN-3 at various concentrations (0-100µg/ml).
HIVI-infected MNC cells were
Copyright 0 1998 by Academic
Press
All rights of reproduction
m any form reserved
1Data
presented at XI International Conference on AIDS, Vancouver BC, Canada,
July 7-12,1996.